Mercedes Gasior Kabat

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui, Alessandro M. Vannucchi, Alberto Álvarez‐Larrán et al. · Leukemia · 2021 · 82 citations · Full text

Medicine, Hematology, Pharmacology +15

Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell–Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric Patients

Mercedes Gasior Kabat, Raquel de Paz, Sergio Querol et al. · Biology of Blood and Marrow Transplantation · 2018 · 56 citations · Full text

Life Sciences, Hematology, Immunology +14

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Tiziano Barbui, Valerio De Stefano, Alberto Álvarez‐Larrán et al. · Blood Cancer Journal · 2021 · 37 citations · Full text

Medicine, Hematology, Internal Medicine +16

Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea

Alberto Álvarez‐Larrán, Marta Garrote, Francisca Ferrer‐Marín et al. · Cancer · 2022 · 32 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

Adrián Mosquera-Orgueira, Manuel Pérez‐Encinas, Alberto Hernández‐Sánchez et al. · HemaSphere · 2022 · 30 citations · Full text

Computing, Biostatistics, Clinical Sciences +17